| Serial Number | 98539735 |
| Word Mark | LDL-C |
| Filing Date | Wednesday, May 8, 2024 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 14, 2026 |
| Registration Number | 8215871 |
| Registration Date | Tuesday, April 14, 2026 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 28, 2025 |
| Goods and Services | providing a website containing information about metabolic diseases and disorders |
| Indication of Colors claimed | The color(s) orange, white, green, blue, and black is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "LDL-C" |
| Description of Mark | The mark consists of a fanciful orange character with white, green, and black eyes. The character is wearing a blue hat with "LDL-C" written in white stylized text. |
| Goods and Services | promoting public awareness about treatments for metabolic diseases and disorders |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 8, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | Tuesday, March 26, 2024 |
| First Use In Commerce Date | Tuesday, March 26, 2024 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 8, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | Tuesday, March 26, 2024 |
| First Use In Commerce Date | Tuesday, March 26, 2024 |
| Party Name | Esperion Therapeutics, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Ann Arbor, MI 48108 US |
| Party Name | Esperion Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Ann Arbor, MI 48108 US |
| Party Name | Esperion Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Ann Arbor, MI 48108 US |
| Event Date | Event Description |
| Wednesday, May 8, 2024 | NEW APPLICATION ENTERED |
| Friday, November 8, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, November 8, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, November 21, 2024 | ASSIGNED TO EXAMINER |
| Thursday, November 21, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, November 21, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, November 21, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, January 2, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, January 2, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, January 3, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, January 3, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 22, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 28, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 28, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 25, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, September 16, 2025 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, September 16, 2025 | SOU EXTENSION 1 FILED |
| Tuesday, September 16, 2025 | SOU EXTENSION 1 GRANTED |
| Tuesday, September 16, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, September 17, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, March 20, 2026 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, September 16, 2025 | USE AMENDMENT FILED |
| Tuesday, March 24, 2026 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, March 24, 2026 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, March 24, 2026 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, April 14, 2026 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, April 14, 2026 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |